Cole Diagnostics is a health care startup founded in 2004 in the United States. It operates as an independent, full-service reference laboratory specializing in various medical diagnostics such as general pathology, skin pathology, women's health, blood and urine chemistry, molecular diagnostics, allergy testing, drug screening, and therapeutic drug monitoring. With its comprehensive range of services, Cole Diagnostics has positioned itself as a key player in the medical diagnostics industry. Although specific details about its last investment and investors are not available, the company's longstanding presence and focus on critical areas of healthcare diagnostics make it an attractive prospect for potential investors. The startup's emphasis on women's health and molecular diagnostics indicates an awareness of evolving healthcare needs and technology. Given the increasing demand for advanced diagnostic services and personalized medicine, Cole Diagnostics appears to be strategically positioned for sustained growth and success in the evolving healthcare landscape.
There is no investment information
No recent news or press coverage available for Cole Diagnostics.
We care about your data, and we'd love to use cookies make your experience better.
